Entrez Id: |
23194 |
Gene Symbol: |
FBXL7 |
FBXL7
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
LINC02484
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
9378 |
Gene Symbol: |
NRXN1 |
NRXN1
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
128178 |
Gene Symbol: |
EDARADD |
EDARADD
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
1615 |
Gene Symbol: |
DARS1 |
DARS1
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
11078 |
Gene Symbol: |
TRIOBP |
TRIOBP
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
ST6GALNAC3
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
6182 |
Gene Symbol: |
MRPL12 |
MRPL12
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
2259 |
Gene Symbol: |
FGF14 |
FGF14
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
9904 |
Gene Symbol: |
RBM19 |
RBM19
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
4175 |
Gene Symbol: |
MCM6 |
MCM6
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
5396 |
Gene Symbol: |
PRRX1 |
PRRX1
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
51555 |
Gene Symbol: |
PEX5L |
PEX5L
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
22871 |
Gene Symbol: |
NLGN1 |
NLGN1
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
2055 |
Gene Symbol: |
CLN8 |
CLN8
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
80714 |
Gene Symbol: |
PBX4 |
PBX4
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
285971 |
Gene Symbol: |
ZNF775 |
ZNF775
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
80114 |
Gene Symbol: |
BICC1 |
BICC1
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
10590 |
Gene Symbol: |
SCGN |
SCGN
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
Entrez Id: |
9568 |
Gene Symbol: |
GABBR2 |
GABBR2
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Ancestry and other genetic associations with plasma PCSK9 response to simvastatin.
|
25089948 |
2014 |
Entrez Id: |
55779 |
Gene Symbol: |
CFAP44 |
CFAP44
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Ancestry and other genetic associations with plasma PCSK9 response to simvastatin.
|
25089948 |
2014 |